Time Activity

0900-0930 Registration
Time Topic
0930-0940 Welcome Message
0940-1000 Study Designs in Medical Research
1000-1020 Ethics & Integrity in Research
1020-1040 Data Management & Analysis
1040-1100 How to do a good Meta-Analysis
1100-1110 Q & A and Discussio
1110-1140 Tea Break
Time Topic
1140-1200 How to Write a Good Research Paper
1200-1220 Translational Research “Its Impact on Health Outcomes”
1220-1240 How to Publish in High Quality Scientific Journals
1240-1300 How to Improve Research Paper before Submission into Journal and Pre-submission Checklist
1300-1310 Q & A and Discussion
1310-1500 Lunch
Time Cases Speaker Supervisor Moderator

1450-1500 Introduction by Workshop Director

1500-1520 Case-1 Hammad Azam Jehanzeb Afridi Masood Siddiq

1520-1540 Case-2 Waqar Ali Shah Adil Naseer Khan

1540-1600 Case-3 Kumail Hassan Kazmi Farrukh Saeed

1600-1610 Wrap up by chairs

1610-1630 Case-4 Ghulam Fareed Amna Subhan Butt Altaf Alam

1630-1650 Case-5 Ajeet Kumar Zahid Azam

1650-1710 Case-6 Hyder Wajid Abbasi Mashood Ali Khan

1710-1720 Wrap up by chairs

1720-1740 Case-7 Adnan Shabbir Akif Dilshad Muhammad Salih

1740-1800 Case-8 Ali Qadeer Zaigham Abbas

1800-1820 Case-9 Umair Shafqat Shahid Rasool

1820-1830 Wrap up by chairs

1900-1930 Dinner

1930 Transfer and Check in Serena Hotel Islamabad

Time Topic
0900-0910 Opening and WELCOME
0910-0925 Who is Spreading Hepatitis What are we doing about it?
0925-0940 Role of Transfusion Services in Prevention of Hepatitis
0940-0955 Decentralizing the HCV Health Care Delivery to Primary Care - is it time?
0955-1010 Good and Simplified Service Delivery for HCV Care in a Resource Limited Country
1010-1025 Key challenges for HCV Elimination in Public Health Domain
1025-1040 Effective Policy for HCV Elimination, Ways and Means
1040-1100
Time Topic
1100-1115 Is Prevention on Back Burner in the Era of DAAs?
1115-1130 Global Progress in Elimination of Hepatitis What do the Numbers Tell us?
1130-1145 Role of Innovation in Technology and delivery approach for Elimination of Viral Hepatitis
1145-1200 HCV Elimination, Lessons from Egypt
1200-1215 Q&A
1215-1230 HCV Elimination in Pakistan
1230-1245 Changing the Behavior Public and Personal - does it Matter?
1245-1300 Media Partnership for HCV and HBV Elimination
1300-1400 Lunch
Time Topic
1400-1415 Role of Professional Bodies In HCV Elimination, Is Some Body Listening?
1415-1430 HEV Vaccine – Immunogenicity and who should be vaccinated
1430-1445 Politics of Advocacy for Hepatitis Elimination - Who should own it?
1445-1505 Patients Perspective

1505-1530 Q&A - Disc

1530 Guests to be seated
1600 Arrival of the Chief Guest
1602 National Anthem
1605 Recitation of The Holy Quran
1610-1615 Welcome Address by The President PSSLD & Chair Organizing Committee
1615-1620 Address by the Representative of Chinese Delegates
1620-1625 Address by the Patron PSSLD
1625-1630 Presentation of Memento to the Chief Guest by the president PSSLD
1630-1635 Speech by Chief Guest
1635 Close of Ceremony
Tea Break
1715-1725 Elimination of Viral Hepatitis - Progress in Azerbaijan
1725-1740 Elimination of Viral Hepatitis - Progress in Bangladesh
1740-1750 Elimination of Viral Hepatitis - Progress in Iran
1750-1800 Elimination of Viral Hepatitis - Progress in Turkey
1800-1810 Elimination of Viral Hepatitis - Progress in China
1810-1830 Change Over
Time Topic
0900-0915 HBV Viral Quasi-species and its Clinical Significance
0915-0930 Effect of Hirudin on Farnessol X Receptor Pathway during Acute Intrahepatic Cholestasis
0930-0945 Nucleoside Analogues Combined with TCM Anti-Fibrosis Ameliorate Prognosis of Chronic Hepatitis B
0945-0950
Time Topic
0955-1020 State of the Art lecture:
HDV Replication and Detection In Hepatocytes
0955-1010 Distribution of HDV Genotypes and its effects on disease course and response to treatment
1010-1025 The Oncogenic role of HDV infection
1025-1040 Epidemiology of HDV Infection in Middle East Countries and Iranian experience with therapy and control of
HDV infection.
1040-1045 HDV Management in 2019 and beyond?
1045-1115 Q&A
1115-1130 Tea Break
1130-1145 Mother to child transmission, HBV Management in Pregnancy
1145-1200 Management of HBV Cirrhotics with and without Co-infection
1200-1215 Management of CHB in Patients with kidney disease
1215-1220 Q&A
1220-1255 State of the Art lecture:
HBV from Functional to Complete Cure, Do East & West Differ in their Approach?
1255-1400 Lunch &
Time Topic
1400-1415 Point of Care Testing in HCV
1415-1430 HCV Treatment Naïve in 2019
1430-1445 Treatment Failure in Era of DAAs
1445-1500 Detection of residual HCV-RNA in patients who have achieved SVR is associated with persistent histological
abnormality
1500-1515 Management of HCV in Decompensated CLD
1515-1530 Post Liver Transplant HCV Treatment
1530-1535 Q&A
1535-1600 State of the Art Lecture:
HCV Management Landscape in Asia - Clinical Reality
1600-1610
Time Topic
1610-1625 Diagnosis of Cirrhosis Staging and Clinical Significance
1625-1640 Management of Ascites in Cirrhotics
1640-1655 Role of Albumin in Cirrhotics Beyond Plasma Expansion
1655-1710 Variceal Bleed, New Developments Building on Old Knowledge
1710-1730
Time Topic
1730-1745 Diagnosis and Management of NAFLD
1745-1800 Hepatic Encephalopathy – A Practical Approach
1800-1815 Optimal and Effective use of Medications in Cirrhotics
1800-1830 Multi detector CT for Hepatic Fibrosis, parameters and accuracy
1830-1845 Pain Management in Cirrhotics
1845-1900 Algorithms in Care of Cirrhosis vs Traditional Approach or Combination - Pros and Cons
1900-1910 Q&A
2000-2045 Dinner
2100 Cultural Evening
Time Topic
0930-0945 What should Pakistan do to have an Effective Surveillance for HCC
0945-1000 HCC treatment BCLS or modified model
1000-1015 Loco regional Curative and Non-Curative Therapies for HCC
1015-1030 Out of criterion TACE for HCC
1030-1045 Out of Criterion LDLT for HCC
1045-1115 Tea br
Time Topic
1115-1130 Imaging in Chronic Liver Disease

1130-1145 Noninvasive Serological Markers of Fibrosis in Chronic Hepatitis

1145-1200 Pathophysiology of NASH
1200-1215 Future Therapies for NASH

Time Topic

1235-1405 Specific Liver Diseases of Pregnancy

1235-1405 NASH

1235-1405 HCV Diagnosis and Treatment

1235-1405 MDT for HCC

 Activity
Registration
Speaker
Masood Siddiq
Dilshad Ahmed Khan
Saeed Sadiq Hamid
Aamir Ijaz
Fasiha Kanwal
Q & A and Discussion
Tea Break
Speaker
Amna Subhan Butt
Syed Mohammad Wasim Jafri
Fasiha Kanwal
ubmission Checklist Yasir Waheed
Q & A and Discussion
Lunch
Moderator Topic Chair persons

Masood Siddiq Refractory Ascites • Kadir

Dockmeci
Acute on Chronic recurrent • Necati Ormeci
Encephalopathy • Rauf Memon
Variceal Bleed Management after
Endoscopy failure

Altaf Alam Sepsis induced ACLF • Seyed Moayed Alavian

• Farrukh
HBV induced ALF Saeed
• Nadeem
DILI (Anti TB Drugs induced) Tehami

Muhammad Salih Pre-transplant Assessment and Transplant • Norah Terrault

in CLD because of NASH • Bilal Hameed
PBC case scenario • Najam Ul
Hasssan Shah
Autoimmune Hepatitis Resistant to
Steroids
 Speakers
Masood Siddiq
Faisal Wasim Ismail
Nuzhat Salamat
re - is it time? Ghias un Nabi Tayyab
source Limited Country Imam Waked
n Fasiha Kanwal
Ministry of Health (Masood)
Tea break
Speakers
Hassan Mahmood
mbers Tell us? Saeed Sadiq Hamid
Elimination of Viral Hepatitis Norah Terrault
Imam Waked
Q&A – Discussion
Huma Qureshi
? Mowadat Hussain Rana
Wasif Nagi – Geo Group
Lunch & Juma Prayer
Speakers
ody Listening? Masood Siddiq
ated Chinese
own it? DG Health
• Khalid Mahmood Gondal
• Ali Noor
Q&A - Discussion

Masood Siddiq
Yuemin Nan
Syed Mohammad Wasim Jafri

Tea Break
Gulnara Aghayeva
Salim Ur Rehman
Seyed Moayed Alavian
Kadir / Necati
Zhongping Duan
Change Over
Speakers
Li Chen
atic Cholestasis Fan Yang
nosis of Chronic Hepatitis B Yuemin Nan
Q&A
Speakers
Mario Rizetto

onse to treatment Gulnara Aghayeva

Zaigham Abbas
ience with therapy and control of Seyed Moayed Alavian

Mario Rizetto

Tea Break
Altaf Alam
Sadik Memon
Arif Mehmood Siddiqui
Q&A
Norah Terrault
proach?
Lunch & Prayer
Speaker
Saeed Sadiq Hamid
Ghias un Nabi Tayyab
Zaigham Abbas
ciated with persistent histological Jinmin Zhao

Bilal Hameed
Norah Terrault

Syed Mohammad Wasim Jafri

Break
Speaker
Muzaffar Latif Gill
Amjad Salamat
Nadeem Tehami
Necati Ormeci
Tea Break
Speaker
Jiangao Fan
Israr Toor
Bilal Hameed
Aman Nawaz Khan Ustrana
Saleem ur Rehman
ros and Cons Fasiha Kanwal
 Dinner
Cultural Evening
Speaker
Zahid Azam
Najam Ul Hassan Shah
Kadir Dockmeci
Atif Rana
Faisal Saud Dar
Tea break
Speaker
Ehsan Kiyani

Habib Jadoon
Mohammad Salih
Bilal Hameed

Target audience Facilitators

General Zaigham Abbas, Lubna Kamani, Amna Subhan Butt,

General Saeed Sadiq Hamid, Bilal Hameed, Mohammad Naseer, Om Prakash

GPs/PGs Syed Mohammad Wasim Jafri, Faisal Wasim Ismail, Naeem

Ullah
PGs Najam ul Hassan Shah, Norah Terrault, Muhammad Salih